Market cap
$95 Mln
Revenue (TTM)
$10 Mln
P/E Ratio
--
P/B Ratio
7.1
Div. Yield
0 %
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
Market cap ($ Mln) |
95 | 809 |
Revenue ($ Mln) |
10 | 182 |
Net Profit ($ Mln) |
-83.80 | 12.56 |
Net Margin (%) |
-850.75 | 6.91 |
RoE (%) |
-- | 5.21 |
Price to Earnings |
-- | 64.50 |
Price-To-Book |
7.09 | 3.39 |
Income Statement ($ Mln)
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
Operating Revenue
|
9.85 | 181.60 |
|
Cost of Revenue
|
13.19 | 123.35 |
|
Gross Profit
|
-5.03 | 62.39 |
|
Operating Expenses
|
67.77 | 43.85 |
|
Operating Profit (EBIT)
|
-71.11 | 14.41 |
|
Other Income
|
0.00 | 0.00 |
|
Profit before Tax
|
-83.44 | 14.38 |
|
Provision for Tax
|
0.36 | 1.82 |
|
Profit after Tax (Net Income)
|
-83.80 | 12.56 |
|
Minority Interest
|
0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 0.00 |
Liabilities ($ Mln)
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
Shareholder's Funds
|
-11.33 | 238.87 |
|
Minority Interest
|
0.00 | 0.00 |
|
Non-Current Liabilities
|
9.91 | 3.94 |
|
Current Liabilities
|
39.92 | 17.54 |
|
Total Liabilities
|
60.53 | 260.83 |
Assets ($ Mln)
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
Non-Current Assets
|
19.06 | 141.09 |
|
Current Assets
|
19.44 | 119.26 |
|
Total Assets
|
60.53 | 260.83 |
|
Total Debt*
|
20.43 | 0.00 |
|
Net Current Assets
|
-20.48 | 101.73 |
Cashflow ($ Mln)
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
Cash From Operating Activities
|
-63.63 | 20.01 |
|
Cash Flow from Investing Activities
|
-- | -- |
|
Cash from Financing Activities
|
9.63 | -17.04 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
ROCE (%)
|
-108.72 | 8.04 |
|
ROE (%)
|
-117.89 | 5.21 |
|
ROA (%)
|
-100.09 | 4.48 |
|
EBIT Margin (%)
|
-721.18 | 6.00 |
|
Net Margin (%)
|
-850.75 | 6.91 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 |
Growth Ratios
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
Revenue Growth (%)
|
39.05 | 6.00 |
|
EBIT Growth (%)
|
9.04 | -55.32 |
|
Net Profit Growth (%)
|
-5.15 | -53.85 |
|
EPS Growth (%)
|
4.87 | -53.85 |
|
Book Value Growth (%)
|
-116.25 | -0.85 |
Valuation Ratios
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
Price / Earnings
|
-1.02 | 39.03 |
|
Price / Book Value
|
2.39 | 3.12 |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
-0.87 | 19.95 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 |
|
Short term debt to equity ratio
|
-1.45 | 0.00 |
|
Current Ratio
|
0.49 | 6.80 |
|
Quick Ratio
|
0.31 | 2.94 |
|
Interest Coverage
|
-122.25 | 118.84 |
Operating Efficiency Ratios
| Asensus Surgical (ASXC) | ATRION Corporation (ATRI) | |
|---|---|---|
|
Debtors to sales (%)
|
4.12 | 14.62 |
|
Asset Turnover
|
0.12 | 0.65 |
|
Receivable days
|
134.53 | 50.67 |
|
Inventory Days
|
207.43 | 252.92 |
|
Payable days
|
100.56 | 31.94 |
|
Cash Conversion Cycle
|
241.39 | 271.65 |